Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD

Overall rate of contraceptive use 5.3 percent of person-years

Risk reduction driven by improvement in insulin resistance, lipoprotein metabolism, and inflammation

In patients with critical findings identified on neuroimaging, most common comorbidities were hypertension, diabetes

Excess deaths seen for specific gender and age groups, with protective effect seen for female children

Most common late effects were endocrine, cardiovascular, respiratory; likelihood of late effects up for those who underwent HSCT

Specifically, perceived support of family members significantly tied to less distress among low-income patients

Prevalence of any current tobacco product use up for men; adults aged ≤65 years; lesbian, gay, bisexual adults

High-risk individuals making modest changes in weight, physical activity had lower odds of progressing to type 2 diabetes

Recommendations and practice points relate to comprehensive care needs, glycemic monitoring, lifestyle interventions